Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.
2.

Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages.

Choi H, Lee RH, Bazhanov N, Oh JY, Prockop DJ.

Blood. 2011 Jul 14;118(2):330-8. doi: 10.1182/blood-2010-12-327353. Epub 2011 May 6.

3.

Transforming growth factor β-transduced mesenchymal stem cells ameliorate experimental autoimmune arthritis through reciprocal regulation of Treg/Th17 cells and osteoclastogenesis.

Park MJ, Park HS, Cho ML, Oh HJ, Cho YG, Min SY, Chung BH, Lee JW, Kim HY, Cho SG.

Arthritis Rheum. 2011 Jun;63(6):1668-80. doi: 10.1002/art.30326.

4.

Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis.

Zhang Q, Shi S, Liu Y, Uyanne J, Shi Y, Shi S, Le AD.

J Immunol. 2009 Dec 15;183(12):7787-98. doi: 10.4049/jimmunol.0902318. Erratum in: J Immunol. 2010 Feb 1;184(3):1656.

5.

Mesenchymal stromal cells.

Bernardo ME, Locatelli F, Fibbe WE.

Ann N Y Acad Sci. 2009 Sep;1176:101-17. doi: 10.1111/j.1749-6632.2009.04607.x. Review.

PMID:
19796238
6.

Cytotoxicity mediated by the Fas ligand (FasL)-activated apoptotic pathway in stem cells.

Mazar J, Thomas M, Bezrukov L, Chanturia A, Pekkurnaz G, Yin S, Kuznetsov SA, Robey PG, Zimmerberg J.

J Biol Chem. 2009 Aug 14;284(33):22022-8. doi: 10.1074/jbc.M109.032235. Epub 2009 Jun 15.

7.

Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans.

Sun L, Akiyama K, Zhang H, Yamaza T, Hou Y, Zhao S, Xu T, Le A, Shi S.

Stem Cells. 2009 Jun;27(6):1421-32. doi: 10.1002/stem.68.

8.

Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner.

Rafei M, Campeau PM, Aguilar-Mahecha A, Buchanan M, Williams P, Birman E, Yuan S, Young YK, Boivin MN, Forner K, Basik M, Galipeau J.

J Immunol. 2009 May 15;182(10):5994-6002. doi: 10.4049/jimmunol.0803962.

9.

Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis.

Liang J, Zhang H, Hua B, Wang H, Wang J, Han Z, Sun L.

Mult Scler. 2009 May;15(5):644-6. doi: 10.1177/1352458509104590.

PMID:
19389752
10.

Mesenchymal stem cells in health and disease.

Uccelli A, Moretta L, Pistoia V.

Nat Rev Immunol. 2008 Sep;8(9):726-36. doi: 10.1038/nri2395. Review.

PMID:
19172693
11.

Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses.

González MA, Gonzalez-Rey E, Rico L, Büscher D, Delgado M.

Gastroenterology. 2009 Mar;136(3):978-89. doi: 10.1053/j.gastro.2008.11.041. Epub 2008 Nov 27.

PMID:
19135996
12.

Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis.

Alex P, Zachos NC, Nguyen T, Gonzales L, Chen TE, Conklin LS, Centola M, Li X.

Inflamm Bowel Dis. 2009 Mar;15(3):341-52. doi: 10.1002/ibd.20753.

13.

Th17 cells undergo Fas-mediated activation-induced cell death independent of IFN-gamma.

Zhang Y, Xu G, Zhang L, Roberts AI, Shi Y.

J Immunol. 2008 Jul 1;181(1):190-6.

14.

IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease.

Polchert D, Sobinsky J, Douglas G, Kidd M, Moadsiri A, Reina E, Genrich K, Mehrotra S, Setty S, Smith B, Bartholomew A.

Eur J Immunol. 2008 Jun;38(6):1745-55. doi: 10.1002/eji.200738129.

15.

CD3-specific antibody-induced immune tolerance involves transforming growth factor-beta from phagocytes digesting apoptotic T cells.

Perruche S, Zhang P, Liu Y, Saas P, Bluestone JA, Chen W.

Nat Med. 2008 May;14(5):528-35. doi: 10.1038/nm1749. Epub 2008 Apr 27.

PMID:
18438416
16.

Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells.

Parekkadan B, Tilles AW, Yarmush ML.

Stem Cells. 2008 Jul;26(7):1913-9. doi: 10.1634/stemcells.2007-0790. Epub 2008 Apr 17.

17.

Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide.

Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI, Zhao RC, Shi Y.

Cell Stem Cell. 2008 Feb 7;2(2):141-50. doi: 10.1016/j.stem.2007.11.014.

18.

Immunomodulatory properties of mesenchymal stromal cells.

Nauta AJ, Fibbe WE.

Blood. 2007 Nov 15;110(10):3499-506. Epub 2007 Jul 30. Review.

19.

Mesenchymal stem cells: a new strategy for immunosuppression?

Uccelli A, Pistoia V, Moretta L.

Trends Immunol. 2007 May;28(5):219-26. Epub 2007 Apr 2. Review.

PMID:
17400510
20.

Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis.

Augello A, Tasso R, Negrini SM, Cancedda R, Pennesi G.

Arthritis Rheum. 2007 Apr;56(4):1175-86.

Supplemental Content

Support Center